Publicaciones en las que colabora con Eva González-Haba Peña (14)

2023

  1. Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents

    Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 7, pp. 2855-2882

  2. Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy

    Frontiers in Oncology, Vol. 13

2022

  1. A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application

    Frontiers in Oncology, Vol. 12

  2. A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital

    Frontiers in Public Health, Vol. 10

  3. Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility

    International Journal of Hematology, Vol. 115, Núm. 1, pp. 61-68

  4. Medication guide for the perioperative management of oral antineoplastic agents in cancer patients

    Expert Opinion on Drug Safety, Vol. 21, Núm. 1, pp. 107-119

2021

  1. Aggressiveness of end-of-life cancer care: what happens in clinical practice?

    Supportive Care in Cancer, Vol. 29, Núm. 6, pp. 3121-3127

  2. Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice

    Supportive Care in Cancer, Vol. 29, Núm. 8, pp. 4673-4681

  3. Error detection and cost savings with an image-based workflow management system connected to a computerized prescription order entry program for antineoplastic compounding

    Journal of Patient Safety, Vol. 17, Núm. 8, pp. E1589-E1594

2020

  1. Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital

    European Journal of Hospital Pharmacy, Vol. 27, Núm. 5, pp. 299-301

  2. Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety

    Health Informatics Journal, Vol. 26, Núm. 3, pp. 1995-2010

2018

  1. Oncology patient interest in the use of new technologies to manage their disease: Cross-sectional survey

    Journal of Medical Internet Research, Vol. 20, Núm. 10

2017

  1. Efectiveness and safety with new treatments in pancreatic cancer

    European Journal of Clinical Pharmacy, Vol. 19, Núm. 4, pp. 233-238

2014

  1. Increased INR after gefitinib and acenocoumarol co-administration

    European Review for Medical and Pharmacological Sciences, Vol. 18, Núm. 12, pp. 1720-1722